Investigation of the Frequency of Hereditary Hyper Alpha-tryptasemia in Patients With Elevated Basal Tryptasemia
NCT06133907
Summary
The aim of the study is to assess the number of patients with elevated blood tryptase for whom this elevation could be linked to a hereditary alpha-tryptase secretion abnormality or hyper-alpha-tryptasemia. This information will enable to better optimize the management and follow-up of patients who have experienced hypersensitivity reactions and have elevated basal blood tryptase levels. The patients will be offered the opportunity to take part in the study. If they consent to participate, they will be tested for hereditary hyper-alpha-tryptasemia. A blood sampling will be performed in the center. A few weeks after, the patient will be informed about the blood sample result during a medical consultation organized in the center.
Eligibility
Inclusion Criteria: * Patients who came in the pneumoallergology department of the CHU de Nice since January 2014 for an allergological workup * Patients who have received at least one basal tryptase assay, according to recommendations * informed consent signature Exclusion Criteria: * High tryptasemia (≥ 8ng/ml) synchronous with anaphylactic reaction and unconfirmed basally * Known diagnosis of systemic mastocytosis
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06133907